The global hemostats market value in 2022 was USD 4 billion driven by the increasing number of surgical procedures across the globe. The market is anticipated to grow at a CAGR of 6.6% during the forecast period of 2023-2031 to achieve a value of USD 7.1 billion by 2031.
North America is the largest market for hemostats, driven by factors such as the advanced healthcare infrastructure, a high number of surgical procedures, and the presence of major hemostat manufacturers.
Europe is the second-largest market, with increasing demand for hemostats due to a growing aging population and a supportive regulatory framework.
Asia Pacific is expected to witness the highest growth rate due to factors such as a rapidly aging population, increasing prevalence of chronic diseases, and growing investments in healthcare infrastructure.
Hemostats Introduction
Hemostats are medical devices or agents used to control bleeding during surgical procedures or traumatic injuries by promoting blood clot formation, sealing blood vessels, or mechanically compressing blood vessels. Hemostats can be classified into several categories, including mechanical hemostats, active hemostats, flowable hemostats, and sealants. They are widely used across various surgical specialties, such as general surgery, cardiovascular surgery, orthopedic surgery, and neurosurgery.Hemostats Market Scenario
The global market has experienced significant growth in recent years, driven by factors such as the increasing number of surgical procedures, an aging global population, advancements in hemostatic materials and technologies, and growing awareness about the importance of proper bleeding control in surgical outcomes.North America is the largest market for hemostats, driven by factors such as the advanced healthcare infrastructure, a high number of surgical procedures, and the presence of major hemostat manufacturers.
Europe is the second-largest market, with increasing demand for hemostats due to a growing aging population and a supportive regulatory framework.
Asia Pacific is expected to witness the highest growth rate due to factors such as a rapidly aging population, increasing prevalence of chronic diseases, and growing investments in healthcare infrastructure.
Hemostats Market Segmentations
Market Breakup by Product Type
- Combination
- Thrombin Based
- Oxidized Regenerated Cellulose Based
- Gelatin Based
- Collagen Based
Market Breakup by Formulation
- Matrix and Gel
- Sheet and Pad
- Sponge
- Powder
- Others
Market Breakup by Applications
- Orthopedic
- General Surgery
- Neurological Surgery
- Cardiovascular Surgery
- Reconstructive Surgery
- Gynecological Surgery
- Others
Market Breakup by Indications
- Closure
- Surgery
Market Breakup by End User
- Ambulatory Centres
- Hospitals
- Clinics
- Community Healthcare
- Others
Market Breakup by Region
North America
- United States of America
- Canada
Europe
- United Kingdom
- Germany
- France
- Italy
- Others
Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
Latin America
- Brazil
- Argentina
- Mexico
- Others
Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Key Trends in the Hemostats Market
Some key trends of the market are as follows:- Advancements in hemostatic materials and technologies: The development of new hemostatic materials, such as advanced biologics and combination products, has improved the performance, safety, and patient outcomes of hemostats, contributing to market expansion
- Growing demand for minimally invasive surgical procedures: The increasing preference for minimally invasive surgical procedures, which typically require specialized hemostatic solutions, has driven market growth and innovation
- Rising awareness about proper bleeding control: Increasing awareness about the importance of proper bleeding control, particularly in the prevention of complications and improvement of surgical outcomes, has led to greater demand for advanced hemostats
Hemostats Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:- CR Bard, Inc
- B. Braun Melsungen AG
- Baxter International, Inc
- Integra Life Sciences
- Marine Polymer Technologies, Inc
- Teleflex
- Ethicon, Inc
- Pfizer, Inc
- Z-Medica LLC
- Gelita Medical GmbH
- Anika Therapeutics, Inc
- Stryker
- Integra Lifesciences Corporation
Table of Contents
1 Preface
3 Global Hemostats Market Overview
4 Global Hemostats Market Landscape
5 Global Hemostats Market Dynamics
6 Global Hemostats Market Segmentation
7 North America Hemostats Market
8 Europe Hemostats Market
9 Asia Pacific Hemostats Market
10 Latin America Hemostats Market
11 Middle East and Africa Hemostats Market
12 Patent Analysis
13 Grants Analysis
14 Funding Analysis
15 Partnership and Collaborations Analysis
16 Regulatory Framework
17 Supplier Landscape
18 Global Hemostats Market-Distribution Model (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
21 Pricing Models and Strategies (Additional Insight)
Companies Mentioned
- Cr Bard, Inc.
- B. Braun Melsungen AG
- Baxter International, Inc.
- Integra Life Sciences
- Marine Polymer Technologies, Inc.
- Teleflex
- Ethicon, Inc.
- Pfizer, Inc.
- Z-Medica LLC
- Gelita Medical GmbH
- Anika Therapeutics, Inc.
- Stryker
- Integra Lifesciences Corporation
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 140 |
| Published | May 2023 |
| Forecast Period | 2023 - 2031 |
| Estimated Market Value ( USD | $ 4.3 Billion |
| Forecasted Market Value ( USD | $ 7.1 Billion |
| Compound Annual Growth Rate | 6.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 13 |
